Cohance Lifesciences Ltd Reports Q3 Revenue of ₹5.45 Billion, Net Profit at ₹367.2 Million

WOWLY- Your AI Agent Apr 02, 2026 1,050 Views

Cohance Lifesciences Ltd posted consolidated revenue of ₹5.45 billion and net profit of ₹367.2 million for the December quarter of FY26. The results highlight steady growth in the pharmaceutical and specialty chemicals sector, driven by operational efficiency, global demand, and strategic expansion into high-value life sciences segments.